AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2013
Feb 8, 2013
29755_dirs_2013-02-08_f74ac59f-b7df-46fc-8b08-3412de151b64.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-02-07
Reporting Person: Schumacher Laura J (EVP, Bus.Dev.,Ext.Aff.&GC)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-07 | Common stock, $0.01 par value | M | 3611 | $32.4681 | Acquired | 211396 | Direct |
| 2013-02-07 | Common stock, $0.01 par value | M | 165 | $32.5720 | Acquired | 211561 | Direct |
| 2013-02-07 | Common stock, $0.01 par value | F | 3466 | $37.14 | Disposed | 208095 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-02-07 | Option (right to buy) | $32.4681 | M | 3611 | Disposed | 2013-02-13 | Common stock (3611) | Direct |
| 2013-02-07 | Option (right to buy) | $32.5720 | M | 165 | Disposed | 2013-02-13 | Common stock (165) | Direct |
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4